Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 58 (RPL31P58)

Target
RPL31P58
Molecular classification
Other (processed pseudogene)
01

Overview

RPL31P58 (ribosomal protein L31 pseudogene 58) is a human processed pseudogene derived from the RPL31 protein-coding gene—one of several ribosomal protein pseudogenes dispersed throughout the genome. Pseudogenes are DNA sequences similar to known genes but are typically non-functional due to mutations acquired over evolutionary time. RPL31P58 is not expressed as protein, is not a therapeutic or diagnostic target, and does not participate in canonical molecular pathways. Its similarity in designation to protein-coding RPL31 can lead to confusion; care should be taken to distinguish the pseudogene (RPL31P58) from the functional ribosomal protein L31 gene (RPL31). RPL31P58 is not a functional protein or clinical drug target; it is a pseudogene with no evidence of protein expression, disease relevance, or therapeutic interaction. Its canonical name is "Ribosomal protein L31 pseudogene 58"; abbreviated as RPL31P58; and it should not be mistaken for the protein-coding ribosomal protein L31 gene.

Other names
RPL31_32_1533RPL31P58

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 58 (RPL31P58).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 58 (RPL31P58).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call